Education and Research

Featured Video: The Future of Patient Care

UT San Diego reports on UC San Diego's Center for the Future of Surgery in, "UCSD facility built to make better doctors," by Paul Sisson.


UC San Diego School of Medicine

David A. Brenner, MD, vice chancellor of UC San Diego Health Sciences and dean of UC San Diego School of Medicine

  • In 2012, David Brenner, MD, and Don W. Cleveland, PhD, chair of the Department of Cellular and Molecular Medicine at UC San Diego School of Medicine, are elected to the Institute of Medicine (IOM) at its 42nd annual meeting. Election to the IOM is considered one of the highest honors in the fields of health and medicine.
  • UC San Diego School of Medicine is ranked 15th in the country in research-intensive programs among 126 medical schools in U.S. News & World Report’s “America’s Best Graduate Schools, 2012 Edition”; its AIDS program in the primary care category is ranked eighth.
  • The School of Medicine’s Center for the Future of Surgery opens in 2011 and is one of the largest facilities in the nation to develop novel surgical technologies, techniques and teaching methods.
  • In 2011, UC San Diego School of Medicine has the eighth highest National Institutes of Health (NIH) total funding of all schools of medicine, according to NIH’s Research Portfolio Online Reporting Tools (RePORT).
  • In 2011, UC San Diego School of Medicine faculty is ranked fourth nationally in research funding per faculty member, according to the Association of American Medical Colleges.
  • UC San Diego School of Medicine is the region’s only medical school, established in 1968.
  • The faculty is made up of more than 1,400 physicians and scientists in 16 academic departments.
  • Joint degree programs with UC San Diego main campus and San Diego State University include public health, clinical psychology and audiology.
  • New Integrative Scientific Curriculum, started August 2010:
    • 125 students accepted each year out of 5,000 applicants
    • Medical Scholars Program, 60 combined bachelor and medical degree students
    • Medical Sciences Training Program, 75 combined MD/PhD students (400 applicants)
    • More than 700 residents and clinical fellows

Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of California, San Diego

Palmer Taylor, PhD, dean

  • 240 PharmD students, 60 PhD students and 30 residents (in 2012)
  • In 2010, Skaggs School of Pharmacy ranks seventh in the nation for NIH funding and second for percentage of PharmD faculty with NIH funding, according to the American Association of Colleges of Pharmacy.
  • Student community service with San Diego Free Clinics and Asian Pacific Center
  • Ongoing clinical and educational partnerships in Taiwan, Europe and Nigeria
  • Admits 60 PharmD students per year and promotes interdisciplinary education and cooperation through shared classes with UC San Diego School of Medicine students
  • Admitted charter class in 2002 and graduated its first class in 2006
  • Second public school of pharmacy in California and the only one in Southern California
  • School is established by the University of California Board of Regents in 2000


UC San Diego Health Sciences Research


arrow bullet Read the current issue of Discoveries Magazine from UC San Diego Health Sciences

Discoveries Magazine

arrow bullet View more UC San Diego Health System facts


  • UC San Diego Moores Cancer Center joins the Salk Institute for Biological Studies and Sanford-Burnham Medical Research Institute to form a novel collaboration — the San Diego National Cancer Institute Cancer Centers Council, or C3. The C3 partnership allows for greater interaction between the cancer centers and increased research efforts leading to better treatments.
  • UC San Diego Health System is collaborating with Qualcomm Life, a wholly owned subsidiary of Qualcomm Technologies, Inc., to pilot the 2netTM Platform and Hub for remote patient monitoring. Qualcomm Life’s innovative 2net technology collects patients’ clinical information from wireless medical devices and transmits it to UC San Diego Health System physicians, to supplement information already available. This system provides a rapid, automated way to collect patient data in near real-time, analyze the readings, and suggest follow-up actions with the patient, if needed.


  • UC San Diego’s research awards for FY 2012 totaled more than $1 billion — an increase of about $50 million over the funding for 2011, according to the Office of Research Affairs at UC San Diego.
  • In FY 2012, combined direct and indirect research funding to Health Sciences faculty alone totaled more than $559 million, according to the Office of Contract and Grant Administration at UC San Diego.
  • An international consortium of scientists studying chronic lymphocytic leukemia (CLL), based at UC San Diego School of Medicine, is awarded a five-year, $20 million grant by the National Cancer Institute, part of the National Institutes of Health. The grant is the second renewal of funding for a broad-based effort designed to better understand the pathology of CLL — the most common form of leukemia in the Western world — in order to develop new drugs and treatments.
  • The governing board of the California Institute for Regenerative Medicine (CIRM) announces that six investigators from UC San Diego Stem Cell Research Program received a total of more than $7 million in CIRM funding, bringing UC San Diego’s total to more than $128 million in CIRM funding since the first awards in 2006.


  • UC San Diego School of Medicine is among 27 research institutions selected across North America to be part of the Cancer Immunotherapy Trials Network, funded by the National Cancer Institute, to establish a network of top academic immunologists to conduct multicenter research on agents that boost patients’ own immune systems in order to fight their cancer.
  • The Sanford Consortium for Regenerative Medicine, which brings together five of the world’s top research institutions — UC San Diego, Sanford-Burnham Medical Research Institute, Salk Institute for Biological Studies, The Scripps Research Institute and La Jolla Institute for Allergy and Immunology — opens a $127 million facility on the campus of UC San Diego to house stem cell researchers from these organizations under one roof.
  • Researchers in the Division of Biomedical Informatics in the Department of Medicine received two federal grants totaling more than $25 million to develop new ways to gather, analyze, use and share vast, ever-increasing amounts of biomedical information.
  • UC San Diego Health Sciences announces a research collaboration with Pfizer through their Center for Therapeutic Innovation, which is aimed at accelerating and transforming drug discovery and development. The potential value to UC San Diego could exceed $50 million in the next five years.
  • Steve and Lisa Altman pledge $10 million towards the building of the Altman Clinical and Translational Research Institute (CTRI) in La Jolla — which will include research laboratories and clinical research space to support UC San Diego medical and bioengineering investigators. The building is slated for completion in early 2016.


  • UC San Diego Health Sciences and its expanding Clinical and Translational Research Institute receive a $37.2 million Clinical Translational Science Award grant to speed up the development of laboratory discoveries into effective treatments for patients.


  • The Institute for Genomic Medicine, formed in June, leverages UC San Diego Health Sciences strengths in basic science, disease biology, pharmacology, engineering, clinical research and computer science/bioinformatics.
  • National Institutes of Health awards UC San Diego School of Medicine researchers an inaugural grant designed to fast-track the development of a novel Alzheimer’s disease therapy as part of its $50 million Blueprint for Neuroscience Research.
  • Roger Tsien, PhD, professor of pharmacology, chemistry and biochemistry at UC San Diego School of Medicine, shares the Nobel Prize in chemistry for his role in helping develop and expand the use of green fluorescent proteins.
  • The Institute of Engineering in Medicine is created to focus on applying engineering principles and techniques to medicine for the creation of innovative and insightful strategies to develop new and unique approaches to health care. It is one of the few institutions in the country to combine the strengths of two major research and teaching enterprises within a university — UC San Diego School of Medicine and UC San Diego Jacobs School of Engineering — in an effort to advance human health.